Valuation: Consort Medical plc

Market Cap 502M 446M 414M 376M 710M 47.64B 721M 4.97B 1.95B 24.86B 1.88B 1.84B 79.24B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 533M 494M 449M 848M 56.88B 861M 5.94B 2.33B 29.68B 2.25B 2.2B 94.62B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 46 2023-01-31
Director/Board Member 52 2024-03-31
Director/Board Member 53 2024-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
2/6/20 Sell 211,474 0.4284%
2/6/20 Exercice 211,474 0.4284%
2/6/20 Sell 467 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
+0.20%+5.31%-18.40%+13.84% 181B
-0.73%+7.09%-1.08%+30.13% 116B
+0.49%+6.25%-21.30%+9.62% 113B
+3.83%+5.50%-50.59%-6.11% 79.83B
-0.14%+5.27%+5.00%+81.87% 65.06B
+2.79%+2.37%+15.85%+65.97% 54.35B
-1.04%+4.35%+1.40%-26.05% 52.23B
+2.41%+8.18%-11.81%+28.50% 44.15B
-1.90%+2.29%+29.19%+6.90% 32.47B
Average +0.59%+4.81%-5.75%+22.74% 73.92B
Weighted average by Cap. +0.60%+5.59%-11.14%+21.17%

Financials

2018 2019
Net sales 311M 277M 256M 233M 440M 29.53B 447M 3.08B 1.21B 15.41B 1.17B 1.14B 49.12B 305M 271M 251M 229M 432M 28.96B 438M 3.02B 1.18B 15.11B 1.15B 1.12B 48.17B
Net income 16.1M 14.31M 13.26M 12.07M 22.77M 1.53B 23.14M 159M 62.51M 797M 60.42M 59.14M 2.54B 10.5M 9.33M 8.65M 7.87M 14.85M 997M 15.09M 104M 40.77M 520M 39.41M 38.57M 1.66B
Net Debt 95.5M 84.89M 78.68M 71.59M 135M 9.06B 137M 946M 371M 4.73B 358M 351M 15.08B 97.4M 86.58M 80.25M 73.01M 138M 9.24B 140M 965M 378M 4.82B 366M 358M 15.38B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock